the plexus into arteries and veins starts only after the plexus has connected to the aorta (the main heart artery), and therefore after the onset of blood flow 5 . But, unexpectedly, Su et al. found that several cells from their embryos, in which the plexus had not yet received blood, had a gene-expression profile associated with mature arteries. They called these cells pre-artery cells.
The authors used a genetic strategy to indelibly label the pre-artery cells with a marker protein, such that these cells and the lineages they give rise to could be tracked during embryonic development. This lineage tracing revealed that, although most pre-artery cells did go on to form coronary arteries, some were incorporated into capillaries, which connect coronary arteries with veins. Thus, it seems that, although certain endo thelial cells are genetically predisposed to form arteries, they also have a degree of developmental plasticity (Fig. 1) .
Next, Su and colleagues performed a detailed analysis of the gene-expression patterns of cells on the developmental spectrum from sinus venosus to pre-artery cells. Changes in gene expression towards more arterial-like profiles occurred only gradually along most of the spectrum. However, there was a sharp change as cells crossed a threshold to adopt a pre-artery state. The researchers showed that the greatest difference in expression in pre-artery cells compared with other cells in their analysis occurred in genes implicated in regulating the cell cycle. Furthermore, in mouse embryos, pre-artery cells proliferated less than did cells in the plexus. Thus, limiting cell divisions might be a prerequisite for coronary artery maturation.
Indeed, the authors found that overexpression of the transcription factor COUP-TF2 in mice inhibited pre-artery formation by up regulating cell-cycle genes. COUP-TF2 was previously thought to limit the growth of arteries by suppressing the Notch signalling pathway 8 . But Su et al. showed that activation of Notch signalling could not prevent the defects caused by COUP-TF2 overexpression in mouse embryos. By contrast, pharmacological inhibition of the cell cycle increased artery formation in an ex vivo experiment. Thus, COUP-TF2 has functions in artery development that are independent of Notch signalling. Together, Su and colleagues' work provides exciting insights into coronary artery formation. It will be interesting to discover whether the findings apply to artery development in other settings.
It will also be valuable to delineate the signalling pathways that lead certain cells to adopt the gene-expression profile of preartery cells. The Notch signalling pathway, acting independently of COUP-TF2, is a prime candidate. Studies in several developmental settings [9] [10] [11] have suggested that new blood-vessel sprouts initially emanate from veins and capillaries and only subsequently form arteries, with each activity inhibiting the other. Inhibiting Notch signalling can lead to excessive blood-vessel sprouting, while at the same time preventing artery formation 12, 13 , and a similar effect is seen during coronary artery development 14 . It will therefore be interesting to investigate how Notch signalling affects the gene-expression profiles that lead to the formation of pre-artery cells.
Although it is becoming increasingly clear that artery differentiation is intimately linked to cell-cycle state, the underpinnings of this relationship need further investigation. A report last year showed that cell-cycle inhibition is important for proper arterial gene expression in cells in vitro 15 . In addition, the signalling pathways involving Notch and vascular endothelial growth factor, which are indispensable for the establishment of new blood-vessel networks, are both implicated in influencing endothelialcell proliferation 16 . However, it is not known how cells interpret signalling inputs from these pathways to balance the demand for proliferation of cells in the blood-vessel network with the need to establish new arteries.
One must also bear in mind that cell-lineage trajectories obtained from scRNA-seq might not reflect true developmental relationships. For instance, cells that have similar gene-expression patterns are not necessarily derived from the same precursor population. New techniques that unite cell-lineage tracing with scRNA-seq 17 will help to bridge this gap, and will surely provide further insights into coronary artery development. ■ 
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M uch of evolutionary biology is motivated by the principle that you cannot understand one species without comparing it with another. When nineteenth-century naturalists compared the anatomies of humans and other apes, it became clear that these species shared many features and had evolved from a common ancestor. More recently, developments in DNA sequencing -which enabled assembly of the human genome 1 in 2001, followed by lower-quality 'draft' genomes for other great apes 2-4 -have transformed our understanding of this evolutionary process. Writing in Science, Kronenberg et al. 5 describe new great-ape genome assemblies, generated using a technology that surpasses previous methods.
This work marks a new stage in our ability to study and compare these species.
Genome assembly is often likened to piecing together a jigsaw puzzle -a huge jigsaw for which the box has been lost and we have only a vague idea of what the whole should look like. The analogy holds because sequencing technologies cannot sequence an entire chromosome in one go. Instead, they fragment the genome into many separate pieces, called reads, which have to be matched, overlapped and placed together.
Previous generations of sequencing machines produced reads that were only about a hundred base pairs long, or perhaps a thousand base pairs but at exorbitant cost. Current machines such as Pacific BioScience's singlemolecule real-time (PacBio SMRT) sequencer produce reads tens of thousands of base pairs in length. Even with this improvement, hundreds
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Newfound differences between great apes
High-quality genome sequences for some of the great apes have been assembled using state-of-the-art sequencing tools. The assemblies provide an unbiased comparison between humans and their closest evolutionary relatives.
of thousands of reads are needed to span a genome of three billion base pairs such as that of humans, Moreover, in practice, a large excess is used (typically more than 30 genomes' worth) to mitigate errors and resolve overlap ambiguities. A further complication arises from the fact that genomes are filled with stretches of DNA in which the same pattern is repeated many times, either in series or scattered throughout the genome. In apes, such repetitive DNA comprises a substantial fraction of the genome.
Because of these difficulties, the first greatape genome projects used the human genome as a scaffold to help assemble genomic regions that are structurally similar to those of humans -that is, in which corresponding stretches of DNA lie in the same order and are present in a similar number of copies. This strategy enabled better assembly in such regions. But in regions where genome structure has evolved very differently in humans and other great apes, the great-ape draft assemblies tended to be more fragmented, and the resulting variation in assembly quality effectively constituted a bias towards the human genome. These assemblies provided many evolutionary insights, but there has nonetheless been a deficit in our understanding of the genomic elements that make humans unique.
One reason why structural variation is important, particularly on the short evolutionary timescale that separates humans and other great apes, is that it provides a way for genomes to evolve rapidly. When a whole chunk of DNA is removed or duplicated, its molecular function can be inhibited or enhanced in one step, rather than through successive mutations at individual bases. Indeed, much of the great-ape genome seems to be modular in nature, and is therefore susceptible to the kind of building-block alteration that structural variation allows. It is also thought that gene loss is a key mechanism for evolutionary change 6, 7 . This might seem counterintuitive, but genes often act to constrain, rather than promote, a particular function. Disabling them by removing, duplicating or relocating a chunk of DNA might be the simplest way to confer beneficial effects.
Kronenberg et al. used PacBio SMRT to assemble high-quality genomes for a chimpanzee and an orangutan, along with two human genomes for comparison (Fig. 1) . The long reads enabled them to do away with the human-genome scaffold used previously, and to increase the typical distance between gaps by about 100-fold compared with previous assemblies. The authors found about 600,000 structural differences between these genomes and that of humans, including more than 17,000 differences specific to humans. Of these, many changes disrupt genes in humans that are not disrupted in other apes. Genes whose activity is suppressed specifically in humans are more likely than other genes to be associated with a human-specific structural variant.
Many genes produce multiple versions, called isoforms, of the protein they encode, each of which can have a different role. Kronenberg and colleagues found evidence that one human-specific structural changea large deletion in the gene FADS2 -might have altered the distribution of isoforms the gene produces. These isoforms are involved in the synthesis of fatty acids needed for brain development and immune response 8 , and are difficult to obtain from a purely herbivorous diet. Correspondingly, FADS2 has been a target for natural selection associated with dietary changes towards or away 5 assembled high-quality genome sequences for a chimpanzee and an orangutan, and compared these with the human genome to look for evolutionary differences.
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"Structural variation also seems to have had a role in brain evolution."
rostate cancer causes more than 300,000 deaths annually worldwide and is one of the most common causes of cancer-linked mortality in men 1 . In 1941, the demonstration 2 that the condition regressed after surgical castration established a link between prostate-cancer growth and androgens -the hormones, such as testosterone, that are mainly generated in the testes and aid the development of male characteristics. The current standard treatment for advanced-stage prostate cancer is androgen depletion by chemical means. However, this almost invariably provides only a temporary halt to the disease. When cancer progression resumes despite low androgen levels, the condition is known as castration-resistant prostate cancer. On page 363, Calcinotto et al. 3 report that the action of immune cells can drive this type of treatment resistance. This discovery could pave the way to new therapeutic options, and illuminates our understanding of the spectrum of interactions in the prostatecancer microenvironment.
The androgen receptor is a protein that can regulate gene expression. Androgendeprivation therapy can lead to prostate-cancer regression because the absence of androgenmediated signalling causes cancer cells to die or cease dividing 4, 5 . The resulting decrease in tumour size is often monitored in the clinic by tracking a decline in the level of a protein called prostate-specific antigen (PSA). Although it was originally thought that castration-resistant prostate cancer arises through mechanisms that are independent of androgen-mediated signalling, certain observations have challenged that. PSA expression is regulated by the androgen pathway, and an increase in the level of PSA almost always accompanies the development of castration-resistant disease 6 . Moreover, clinical improvement can occur when people undergoing androgen-deprivation therapy are also given extra treatments that hamper androgen signalling 7 . A range of mechanisms underlying castration-resistant prostate cancer have been reported 8 , and several causes probably contribute to disease progression in any given individual. The identification of mechanisms associated with disease progression has led to the development of associated treatments. For example, up to half of castration-resistant prostate cancers 9 are accompanied by an increase in the number of copies of the androgen-receptor gene. This, along with other clues suggesting that androgen-receptor expression correlates with disease progression, has stimulated the generation of drugs that can inhibit the androgen receptor 10 . Castration resistance can also occur through an increase in the expression of enzymes that synthesize androgens, and this discovery led to the development of drugs that inhibit androgen biosynthesis 11 . However, resistance to both these types of inhibitor can develop, so there is still a need for additional clinical strategies.
Calcinotto and colleagues investigated whether immune cells might aid the development of castration-resistant prostate cancer. They focused on an immune-cell population known as myeloid-derived suppressor cells (MDSCs), which includes monocytes and neutrophils that might be in an immature state of abnormal activation. MDSC presence is linked to poor prognosis for patients who have prostate cancer 12 , although this connection has been attributed to the suppression of an anticancer immune response. Calcinotto et al. observed that tumour bi opsies from people who have developed castration-resistant prostate cancer contain more MDSCs that express the proteins CD11b, CD33 and CD15 than do samples from people whose prostate cancer has not progressed to the castration-resistant stage.
The authors investigated whether MDSCs might contribute directly to castration resistance, using human cell samples and mouse models of prostate cancer. In mice, the authors found that surgical castration resulted in an increase in the recruitment of MDSCs to tumours, compared with the recruitment observed in control animals given a mock operation. Calcinotto and colleagues grew mouse MDSCs in vitro and isolated samples of the culture medium. When this medium was added to androgen-dependent from animal fats in recent human evolution 8 . Chimpanzees eat a small amount of meat, so it is not known what (if any) human-specific traits might have resulted from this deletion, but it does suggest that shifting dietary patterns could have been a feature of human evolution over long timescales.
Structural variation also seems to have had a role in brain evolution. Human brains are much larger than those of other apes, and it is plausible that genes involved in brain growth and development were key to the evolution of this trait. The authors analysed the sequences of genes that are active in radial glial cells, which are progenitors for neurons and other cells in the brain's cortex, and compared protein production by these genes in humans and chimpanzees using cortical organoids -3D models of brain tissue grown in vitro. These analyses revealed that 41% of genes whose activity is suppressed in human radial glial cells are associated with a human-specific structural variant. Again, this is consistent with structural genomic changes causing disruption or loss of gene function during great-ape evolution.
Intriguing as Kronenberg and colleagues' findings are, there is also a broader significance to their work. Several groups and consortia are applying new sequencing technologies to different organisms. Ultimately, researchers want accurate, high-resolution assemblies for all species, and to compare these genomes on an equal footing. This will improve evolutionary analyses and reveal complex mutation processes that have hitherto been obscured. Large genome assembly currently remains hugely expensive, and even state-of-the-art sequencing tools struggle to resolve repetitive sequences on scales above a few hundred thousand base pairs, making assembly of certain genomes challenging. But tools to read whole genomes with negligible errors on inexpensive hardware are not far away, and are almost available for small bacterial genomes 9 .
It is clear that we are leaving behind the 
